A method of predicting infectious complications in patients with multiple myeloma

摘要

A method of predicting infectious complications in patients with multiple myeloma by blood tests, characterized in that in serum by enzyme immunoassay determine levels of proinflammatory cytokines - tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) and the level of anti-inflammatory cytokine - interleukin-4 (IL-4) and TNF-alpha levels above 0.5 pg / ml, IL-2 is higher than 10 pg / ml of IL-4 and below 0.55 pg / ml predicts development of infectious complications in patients with myeloma disease.